Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Thu., Apr. 18, 11:15 PM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
Slide #53. Perrigo Company plc — Elan Corporation, plc
Acquirer: |
Perrigo Company plc (NYSE:PRGO) |
Acquiree: |
Elan Corporation, plc |
Details: |
Perrigo Company plc (NYSE, TASE: PRGO) ("Perrigo") and Elan Corporation, plc ("Elan") today announced that Perrigo has completed the acquisition of Elan in a cash and stock transaction valued on the date of the announcement at approximately US$8.6 billion. The transaction will create a global healthcare company with an industry-leading growth profile and the geographic scale and scope to continue building a truly differentiated business. |
Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
PRGO SEC Filing Email Alerts Service
Open the PRGO Page at The Online Investor »
Company Name: |
Perrigo Company plc |
Website: |
www.perrigo.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding PRGO: |
68 |
Total Market Value Held by ETFs: |
$868.02M |
Total Market Capitalization: |
$4.06B |
% of Market Cap. Held by ETFs: |
21.38% |
|
Open the PRGO Page at The Online Investor (in a new window) »
|
April 18, 2024 11:15 PM Eastern
Strong Buy (4.00 out of 4)
100th percentile
|
|